SCHEMBL21574194

SCHEMBL21574194

Cn1nc(C(O)O)c2c1-c1cc(F)ccc1OC2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 3/20 0.43
▸ MAPT P10636 6/20 0.42
▸ NR1H4 Q96RI1 6/20 0.41
▸ PGR P06401 3/20 0.37
▸ NR3C2 P08235 3/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ PIK3CD O00329 1/20 0.36
▸ PIK3R2 O00459 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ PIK3R5 Q8WYR1 1/20 0.36
▸ PIK3R3 Q92569 1/20 0.36
▸ AR P10275 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ NOTUM Q6P988 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2173369 0.79 NR1H4 (0.53) THRBMAPTNR1H4PIK3CDPIK3R2
SCHEMBL21574265 0.78 THRB (0.43) THRBMAPTNR1H4PGRNR3C2
SCHEMBL22299813 0.76 MAPT (0.54) MAPTNR1H4KDM4EALDH1A1GAA
SCHEMBL2171061 0.74 MAPT (0.46) THRBMAPTNR1H4PGRNR3C2
SCHEMBL2549040 0.74 TP53 (0.55) MAPTNR1H4KDM4EALDH1A1POLB
SCHEMBL19910470 0.71 NR1H4 (0.43) THRBMAPTNR1H4PGRNR3C2
SCHEMBL2171176 0.69 MAPT (0.46) MAPTNR1H4PGRNR3C2PIK3CD
SCHEMBL2546279 0.69 MAPT (0.55) THRBMAPTNR1H4KDM4EALDH1A1
SCHEMBL19910458 0.68 NR1H4 (0.66) NR1H4
SCHEMBL21574193 0.68 MAPT (0.44) THRBMAPTNR1H4PGRNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288948-B1 FUSED TRICYCLIC PYRAZOLE DERIVATIVES USEFUL FOR MODULATING FARNESOID X RECEPTORS NOVARTIS AG (CH) 2019-11-20 — — EP disclosed
Send feedback